MUSCAT: Dasman Diabetes Institute (DDI), founded by Kuwait Foundation for the Advancement of Sciences (KFAS), took part in the Gulf Chapter of the Seventh Annual Clinical Congress by the American Association of Clinical Endocrinologists. The conference was held in Muscat, Oman from the period of 10th until 12th October 2019.
Dr Ebaa Al-Ozairi, Chief Medical Officer of DDI, who was elected to be the first female president of the Annual Clinical Congress for this year, inaugurated, chaired and presented many sessions and lectures at the conference. Many other healthcare professionals and specialists from the Institute and the region attended this conference and presented as well. There were more than 1000 delegates and high-profile international speakers. Dr Ozairi also chaired the diabetes educator course, an innovative addition to the Annual Congress with speakers from Dasman Diabetes Institute. The Institute also had posters and abstracts highlighting the importance of Remission Clinic at the Institute.
Furthermore, Dasman Diabetes Institute participated in this conference by setting-up their own booth. The Public Relations and Media team was present to provide booklets, brochures and giveaways to the conference participants, as well as answer any queries, and showcasing the new research and innovative clinics like the Diabetes Remission and others. Dasman Diabetes Institute continues to direct its efforts to address the diabetes epidemic through focused diabetes research, integrated prevention, training and education.
Dr Ozairi has completed her intercalated BMSc(hons) in molecular pathology at Dundee University (UK) and graduated from Aberdeen University (UK) for her medical undergraduate studies. Dr Ozairi then joined Newcastle University (UK) for her specialist training in Diabetes and Endocrinology. During her postgraduate studies in UK, Dr Ozairi was awarded The Fulbright fellowship to Joslin Diabetes Institute, affiliates of Harvard medical school, Boston, USA.
Her research interest includes diabetes education, technology and metabolic surgery. Dr Ozairi has been accredited by the Royal College of physician (UK) as a medical educator, and is an associate practitioner at the UK Higher Education National Academy having completed teaching fellowship. Dr Ozairi has completed her Rabkin Fellowship in medical Education at Harvard Medical school.